Involvement of hypothalamic PI3K-STAT3 signalling in regulating appetite suppression mediated by amphetamine

British Journal of Pharmacology

Volumn 171, Issue 13, 2014, Pages 3223-3233

  Chu, Shu Chen ^a   Chen, Pei Ni ^b   Hsieh, Yih Shou ^b   Yu, Ching Han ^b   Lin, Meng Hsuan ^b   Lin, Yan Han ^b   Kuo, Dong Yih ^b  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

appetite; brain; NPY; PI3K; POMC; STAT3

Indexed keywords

AMPHETAMINE; ANTISENSE OLIGONUCLEOTIDE; MELANOCORTIN 3 RECEPTOR; NEUROPEPTIDE Y; PHOSPHATIDYLINOSITOL 3 KINASE; PROOPIOMELANOCORTIN; STAT3 PROTEIN; ANOREXIGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECREASED APPETITE; DOWN REGULATION; DRUG RESPONSE; FEEDING BEHAVIOR; HYPOTHALAMUS; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEIC ACID PROBE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; RAT MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WEIGHT CHANGE; WESTERN BLOTTING; ANIMAL; APPETITE; DRUG EFFECTS; FOOD INTAKE; METABOLISM; NERVE CELL; PHOSPHORYLATION; WISTAR RAT;

AMPHETAMINE; ANIMALS; APPETITE; APPETITE DEPRESSANTS; APPETITE REGULATION; BLOTTING, WESTERN; HYPOTHALAMUS; MALE; NEURONS; NEUROPEPTIDE Y; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PRO-OPIOMELANOCORTIN; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84902212522     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12667     Document Type: Article

References (57)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. Br J Pharmacol 170: 1459-1581.
2. Aberg MA, Ryttsén F, Hellgren G, Lindell K, Rosengren LE, MacLennan AJ, et al. (2001). Selective introduction of antisense oligonucleotides into single adult CNS progenitor cells using electroporation demonstrates the requirement of STAT3 activation for CNTF-induced gliogenesis. Mol Cell Neurosci 17: 426-443.
3. Ajeawung NF, Wang HY, Gould P, Kamnasaran D, (2012). Advances in molecular targets for the treatment of medulloblastomas. Clin Invest Med 35: E246.
4. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G, (2001). Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21:RC141: 1-4.
5. Chee MJ, Myers MG Jr, Price CJ, Colmers WF, (2010). Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus. J Neurosci 30: 3380-3390.
6. Chen PN, Chu SC, Chiou HL, Kuo WH, Chiang CL, Hsieh YS, (2006). Mulberry anthocyanins, cyanidin 3-rutinoside and cyaniding 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Lett 235: 248-259.
7. Chen TY, Duh SL, Huang CC, Lin TB, Kuo DY, (2001). Evidence for the involvement of dopamine D1 and D2 receptors in mediating the decrease of food intake during repeated treatment with amphetamine. J Biomed Sci 8: 462-466.
8. Chomczynski P, Sacchi N, (1987). Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
9. Donato J Jr, Frazão R, Elias CF, (2010). The PI3K signaling pathway mediates the biological effects of leptin. Arq Bras Endocrinol Metabol 54: 591-602.
10. Dziennis S, Alkayed NJ, (2008). Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 19: 341-361.
11. Ernst MB, Wunderlich CM, Hess S, Paehler M, Mesaros A, Koralov SB, et al. (2009). Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. J Neurosci 29: 11582-11593.
12. Gong L, Yao F, Hockman K, Heng HH, Morton GJ, Takeda K, et al. (2008). Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neuropeptide Y neurons for normal energy homeostasis. Endocrinology 149: 3346-3354.
13. He G, Karin M, (2011). NF-κB and STAT3-key players in liver inflammation and cancer. Cell Res 21: 159-168.
14. Hill JW, Williams KW, Ye C, Luo J, Balthasar N, Coppari R, et al. (2008). Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J Clin Invest 118: 1796-1805.
15. Horvath TL, Naftolin F, Kalra SP, Leranth C, (1992). Neuropeptide-Y innervation of beta endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis. Endocrinology 131: 2461-2467.
16. Hsieh YH, Chen PN, Yu CH, Liao JM, Kuo DY, (2013). Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NFkB-mediated feeding behavior in phenylpropanolamine-treated rats. Horm Behav 64: 95-102.
17. Hsieh YS, Hsu JD, Yang SF, Kuo DY, (2004). Immunohistochemical and genomic evidence for the involvement of hypothalamic neuropeptide Y in phenylpropranolamine-mediated appetite suppression. Peptides 25: 2155-2161.
18. Hsieh YS, Yang SF, Kuo DY, (2005). Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum. Regul Pept 127: 169-176.
19. Hsieh YS, Yang SF, Chiou HL, Kuo DY, (2006). Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. Toxicol Appl Pharmacol 212: 99-109.
20. Hsieh YS, Yang SF, Kuo DY, (2007). Intracerebral administration of protein kinase A (PKA) or c-AMP response element binding protein (CREB) antisense oligonucleiotide can modulate amphetamine-mediated appetite suppression in free-moving rats. Am J Physiol Endocrinol Metab 292: 123-131.
21. Hsieh YS, Yang SF, Chen PN, Chu SC, Chen CH, Kuo DY, (2011). Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats. J Psychopharmacol 25: 982-994.
22. Ju KD, Lim JW, Kim KH, Kim H, (2011). Potential role of NADPH oxidase-mediated activation of Jak2/Stat3 and mitogen-activated protein kinases and expression of TGF-β1 in the pathophysiology of acute pancreatitis. Inflamm Res 60: 791-800.
23. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
24. Kim KS, Yoon YR, Lee HJ, Yoon S, Kim SY, Shin SW, et al. (2010). Enhanced hypothalamic leptin signaling in mice lacking dopamine D2 receptors. J Biol Chem 285: 8905-8917.
25. Kuo DY, (2005). Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats. Regul Pept 127: 19-26.
26. 2 agonists. Br J Pharmacol 148: 640-647.
27. Kuo DY, Yang SF, Chu SC, Chen CH, Hsieh YS, (2009). Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling. Chem Biol Interact 180: 193-201.
28. Kuo DY, Chen PN, Yang SF, Chu SC, Chen CH, Kuo MS, et al. (2011). Role of reactive oxygen species-related enzymes in neuropeptide Y and proopiomelanocortin-mediated appetite control: a study using atypical protein kinase C knockdown. Antioxid Redox Signal 15: 2147-2159.
29. Kuo DY, Chen PN, Yu CH, Kuo MH, Hsieh YS, Chu SC, (2012a). Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression. Neuropharmacology 63: 842-850.
30. Kuo DY, Chen PN, Kuo MH, Chen CH, Hsieh YS, Chu SC, (2012b). NF-kappaB knockdown can modulate amphetamine-mediated feeding response. Neuropharmacology 62: 1684-1694.
31. Law AJ, Wang Y, Sei Y, O-2Donnell P, Piantadosi P, Papaleo F, et al. (2012). Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy. Proc Natl Acad Sci U S A 109: 12165-12170.
32. Lee YW, Son KW, Flora G, Hennig B, Nath A, Toborek M, (2002). Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain. J Neurosci Res 70: 82-89.
33. Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, et al. (2006). Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res 12: 7140-7148.
34. Luwor RB, Stylli SS, Kaye AH, (2013). The role of Stat3 in glioblastoma multiforme. J Clin Neurosci 20: 907-911.
35. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
36. Magni P, Barnea A, (1992). Forskolin and phorbol ester stimulation of neuropeptide Y (NPY) production and secretion by aggregating fetal brain cells in culture: evidence for regulation of NPY biosynthesis at transcriptional and posttranscriptional levels. Endocrinology 130: 976-984.
37. Mercer RE, Chee MJ, Colmers WF, (2011). The role of NPY in hypothalamic mediated food intake (Review). Front Neuroendocrinol 32: 398-415.
38. Morales-Medina JC, Dumont Y, Quirion R, (2010). A possible role of neuropeptide Y in depression and stress. Brain Res 1314: 194-205.
39. Morrison CD, Morton GJ, Niswender KD, Gelling RW, Schwartz MW, (2005). Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. Am J Physiol Endocrinol Metab 289: E1051-E1057.
40. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers MG Jr, Schwartz MW, (2001). Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413: 794-795.
41. Ogawa S, Pfaff DW, (1998). Current status of antisense DNA methods in behavioral studies. Chem Senses 23: 249-255.
42. Paxinos G, Watson C, (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: Sydney.
43. Rajan P, (2011). STATus and context within the mammalian nervous system. Mol Med 17: 965-973.
44. Rau TF, Kothiwal A, Zhang L, Ulatowski S, Jacobson S, Brooks DM, et al. (2011). Low dose methamphetamine mediates neuroprotection through a PI3K-AKT pathway. Neuropharmacology 61: 677-686.
45. Riediger T, Cordani C, Potes CS, Lutz TA, (2010). Involvement of nitric oxide in lipopolysaccharide induced anorexia. Pharmacol Biochem Behav 97: 112-120.
46. Ritter RC, Slusser PG, Stone S, (1981). Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 213: 451-452.
47. Roman EAFR, Reis D, Romanatto T, Maimoni D, Ferreira EA, Santos GA, et al. (2010). Central leptin action improves skeletal muscle AKT, AMPK, and PGC1[alpha] activation by hypothalamic PI3K-dependent mechanism. Mol Cell Endocrinol 314: 62-69.
48. Sahu A, (2011). Intracellular leptin-signaling pathways in hypothalamic neurons: the emerging role of phosphatidylinositol-3 kinase-phosphodiesterase- 3B-cAMP pathway. Neuroendocrinology 93: 201-210.
49. Schwartz MW, (2006). Central nervous system regulation of food intake. Obesity (Silver Spring) 14 (Suppl. 1): 1S-8S.
50. Sohn JW, Williams KW, (2012). Functional heterogeneity of arcuate nucleus pro-opiomelanocortin neurons: implications for diverging melanocortin pathways. Mol Neurobiol 45: 225-233.
51. Spielewoy C, Biala G, Roubert C, Hamon M, Betancur C, Giros B, (2001). Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology (Berl) 159: 2-9.
52. Wen Z, Zhong Z, Darnell JE Jr, (1995). Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.
53. Xu AW, Ste-Marie L, Kaelin CB, Barsh GS, (2007). Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding. Endocrinology 148: 72-80.
54. Yu L, Chen C, Wang LF, Kuang X, Liu K, Zhang H, et al. (2013). Neuroprotective effect of kaempferol glycosides against brain injury and neuroinflammation by inhibiting the activation of NF-κB and STAT3 in transient focal stroke. PLoS ONE 8: e55839.
55. Zgheib C, Kurdi M, Zouein FA, Gunter BW, Stanley BA, Zgheib J, et al. (2012). Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitive. PLoS ONE 7: e43313.
56. Zhang M, Creese I, (1993). Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci Lett 161: 223-226.
57. Zhong Z, Wen Z, Darnell JE Jr, (1994). Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98.